Literature DB >> 11950579

Use of the blood transfusion service in total knee replacement arthroplasty. The cost implications.

V G Hadjianastassiou1, G Virich, I A Lennox.   

Abstract

In view of the rising costs of blood transfusion and reports of inappropriate transfusions an audit of the local practice was organised. The aim was to investigate whether blood transfusion in primary unilateral Total Knee replacement Arthroplasty (TKA) operations was being used inappropriately locally, the resultant cost implications and suggest ways of reducing these. A 1-year retrospective survey of blood transfusion practice was conducted for all consecutive elective, primary, unilateral TKA operations at a District-General Hospital. 169 operations were performed and 58 (34%) patients were transfused. A retrospective Haemoglobin concentration (Hb) analysis was performed for all the transfused patients to identify the number of transfusions that satisfied the suggested transfusion criteria of a threshold Hb of 8 g/dl and when indicated, a minimum transfusion of 2 units. Complete transfusion data was available on 49/58 (84%) patients transfused. When applying the above criteria to this sample, the potential annual saving for the department was estimated at approximately 8000 pounds Sterling; only 9 of these patients were deemed to be appropriately transfused.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11950579     DOI: 10.1016/s0968-0160(02)00013-3

Source DB:  PubMed          Journal:  Knee        ISSN: 0968-0160            Impact factor:   2.199


  3 in total

Review 1.  Cell salvage for minimising perioperative allogeneic blood transfusion.

Authors:  Paul A Carless; David A Henry; Annette J Moxey; Dianne O'Connell; Tamara Brown; Dean A Fergusson
Journal:  Cochrane Database Syst Rev       Date:  2010-04-14

2.  Closed suction drains do not increase the blood transfusion rates in patients undergoing total knee arthroplasty.

Authors:  R O Sundaram; R W Parkinson
Journal:  Int Orthop       Date:  2006-09-01       Impact factor: 3.075

Review 3.  Hemoglobin level at initiation of darbepoetin alfa: impact on need for transfusion and associated costs in chemotherapy-induced anemia treatment in Europe.

Authors:  Melike Deger; Wolfgang Eisterer; Lucie Kutikova; Sam Salek
Journal:  Support Care Cancer       Date:  2012-07-24       Impact factor: 3.603

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.